STAT+: FDA declares Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance
The FDA has declared a Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance, which could delay approval of drugs made at the Indiana facility.
